Merck logo (to the Merck website)
Home· | Merck Group· | Contact· | Deutsch · | Sitemap· | Search
  • Index
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15

Notes to the consolidated income statement Audited

  • [1] Sales
  • [2] Royalty, license and commission income
  • [3] Cost of sales
  • [4] Marketing and selling expenses
  • [5] Royalty, license and commission expenses
  • [6] Administration expenses
  • [7] Other operating expenses and income
  • [8] Research and development
  • [9] Amortization of intangible assets
  • [10] Investment result
  • [11] Exceptional items
  • [12] Financial result
  • [13] Income tax
  • [14] Non-controlling interest
  • [15] Earnings per share
previous page back   next next page

SERVICES

  • Recommend page
  • Print page
  • Compare to 2010
  • Order online
  • Glossary
  • Downloads

CHART GENERATOR

Important key figures
previous page back   next next page
top  
Imprint, © Merck KGaA, Darmstadt, Germany, Last Update 2012/03/06
  • Home
  • Merck 2011 at a glance
  • Corporate Governance
  • Merck in the Capital Market
  • Group Management Report
  • Merck Serono
  • Consumer Health Care
  • Merck Millipore
  • Performance Materials
  • Financial Statements
  • Notes
    • Scope of consolidation
    • Accounting policies
    • Notes to the consolidated income statement
    • Notes to the consolidated balance sheet
    • Segment reporting
    • Notes to the consolidated cash flow statement
    • Other disclosures
    • Auditor’s Report
  • The road to tomorrow
made by Nexxar - your next annual report online!, Vienna - Austria